Cat: IPD-X40216

Recombinant Nostoc sp. patA Protein ,His & Myc

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    patA

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    PAT-1

  • Species

    Nostoc sp.

  • Source

    E. coli

  • Tag

    N- His & C- Myc

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    P39048

  • Expression Region

    1-379aa

  • Molecular Weight

    50.2 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

PatA is a protein that plays a significant role in the pathogenesis of certain bacterial species, particularly in the context of antibiotic resistance mechanisms. Research into PatA has gained prominence due to its involvement in the biosynthesis of cyclic di-GMP, a crucial secondary messenger that regulates various cellular processes, including biofilm formation and virulence factors. The understanding of PatA's structure and function is critical, as it offers insights into potential targets for novel antimicrobial therapies. By generating recombinant forms of PatA, researchers aim to elucidate its biochemical properties and the mechanisms by which it contributes to bacterial survival and adaptation. Studies involving the expression and purification of PatA can lead to the identification of specific inhibitors, offering a strategic approach to combat bacterial infections that exhibit multidrug resistance. Furthermore, investigating the interactions of PatA with other molecular players within the bacterial cell can enhance our comprehension of its role in cellular signaling pathways, thus potentially guiding the development of more effective treatment options. As antibiotic resistance continues to pose a global health threat, the exploration of proteins like PatA is essential for advancing our understanding of bacterial physiology and enabling innovative solutions for infection control.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US